Year |
Citation |
Score |
2022 |
Omar IS, Mat Adenan NA, Godoy A, Teo IH, Gunasagran Y, Chung I. Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium. Biochemical and Biophysical Research Communications. 628: 133-140. PMID 36084551 DOI: 10.1016/j.bbrc.2022.08.088 |
0.317 |
|
2022 |
Voon YC, Omar IS, Wu MH, Said NABM, Chung I. Cancer-associated fibroblasts as cellular vehicles in endometrial cancer cell migration. Oncology Letters. 23: 3. PMID 34820002 DOI: 10.3892/ol.2021.13121 |
0.318 |
|
2020 |
Kwong SC, Abd Jamil AH, Rhodes A, Taib NA, Chung I. Fatty acid binding protein 7 mediates linoleic acid-induced cell death in triple negative breast cancer cells by modulating 13-HODE. Biochimie. PMID 32931863 DOI: 10.1016/J.Biochi.2020.09.005 |
0.314 |
|
2020 |
Nalairndran G, Hassan Abdul Razack A, Mai CW, Fei-Lei Chung F, Chan KK, Hii LW, Lim WM, Chung I, Leong CO. Phosphoinositide-dependent Kinase-1 (PDPK1) regulates serum/glucocorticoid-regulated Kinase 3 (SGK3) for prostate cancer cell survival. Journal of Cellular and Molecular Medicine. PMID 32926495 DOI: 10.1111/Jcmm.15876 |
0.389 |
|
2019 |
Lai SL, Tan ML, Hollows RJ, Robinson M, Ibrahim M, Margielewska S, Parkinson EK, Ramanathan A, Zain RB, Mehanna H, Spruce RJ, Wei W, Chung I, Murray PG, Yap LF, et al. Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1. Cancers. 11. PMID 31717573 DOI: 10.3390/Cancers11111766 |
0.364 |
|
2019 |
Kwong SC, Abd Jamil AH, Rhodes A, Taib NA, Chung I. Metabolic role of fatty acid binding protein 7 in mediating triple negative breast cancer cell death via PPAR-alpha signalling. Journal of Lipid Research. PMID 31484694 DOI: 10.1194/Jlr.M092379 |
0.34 |
|
2017 |
Cheong JE, Zaffagni M, Chung I, Xu Y, Wang Y, Jernigan FE, Zetter BR, Sun L. Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry. 144: 372-385. PMID 29288939 DOI: 10.1016/J.Ejmech.2017.11.037 |
0.348 |
|
2017 |
Yap CV, Subramaniam KS, Khor SW, Chung I. Annonacin Exerts Antitumor Activity through Induction of Apoptosis and Extracellular Signal-regulated Kinase Inhibition. Pharmacognosy Research. 9: 378-383. PMID 29263632 DOI: 10.4103/Pr.Pr_19_17 |
0.319 |
|
2016 |
Wu YS, Chung I, Wong WF, Masamune A, Sim MS, Looi CY. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochimica Et Biophysica Acta. PMID 27750041 DOI: 10.1016/J.Bbagen.2016.10.006 |
0.317 |
|
2016 |
Wu YS, Looi CY, Subramaniam KS, Masamune A, Chung I. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. Oncotarget. PMID 27167341 DOI: 10.18632/Oncotarget.9165 |
0.396 |
|
2014 |
Banyard J, Chung I, Migliozzi M, Phan DT, Wilson AM, Zetter BR, Bielenberg DR. Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer. Bmc Cancer. 14: 387. PMID 24885350 DOI: 10.1186/1471-2407-14-387 |
0.309 |
|
2014 |
Lee ML, Fung SY, Chung I, Pailoor J, Cheah SH, Tan NH. King cobra (Ophiophagus hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model. International Journal of Medical Sciences. 11: 593-601. PMID 24782648 DOI: 10.7150/Ijms.8096 |
0.431 |
|
2014 |
Li Lee M, Chung I, Yee Fung S, Kanthimathi MS, Hong Tan N. Antiproliferative activity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase. Basic & Clinical Pharmacology & Toxicology. 114: 336-43. PMID 24118879 DOI: 10.1111/Bcpt.12155 |
0.358 |
|
2014 |
Chung I, Subramaniam KS, Tham ST, Mohamed Z, Adenan NAM, Woo YL. Abstract 1078: Cancer-associated fibroblasts promote endometrial cancer cell proliferation in vitro and in vivo Tumor Biology. 74: 1078-1078. DOI: 10.1158/1538-7445.Am2014-1078 |
0.462 |
|
2013 |
Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD, di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Research. 73: 6359-74. PMID 24097820 DOI: 10.1158/0008-5472.Can-13-1558-T |
0.303 |
|
2013 |
Subramaniam KS, Tham ST, Mohamed Z, Woo YL, Mat Adenan NA, Chung I. Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells Plos One. 8. PMID 23922669 DOI: 10.1371/Journal.Pone.0068923 |
0.429 |
|
2013 |
Godoy AS, Chung I, Montecinos VP, Buttyan R, Johnson CS, Smith GJ. Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate. American Journal of Physiology. Endocrinology and Metabolism. 304: E1131-9. PMID 23548616 DOI: 10.1152/Ajpendo.00602.2012 |
0.529 |
|
2012 |
Olsen RR, Chung I, Zetter BR. Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids. 42: 549-58. PMID 21909979 DOI: 10.1007/S00726-011-1032-X |
0.438 |
|
2011 |
Spivey KA, Chung I, Banyard J, Adini I, Feldman HA, Zetter BR. A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene. 31: 2362-72. PMID 21963851 DOI: 10.1038/Onc.2011.406 |
0.394 |
|
2011 |
Olsen RR, Chung I, Zetter BR. Abstract 248: Control of prostate tumor growth and centriole amplification by antizyme and antizyme inhibitor Cancer Research. 71: 248-248. DOI: 10.1158/1538-7445.Am2011-248 |
0.328 |
|
2010 |
Johnson CS, Chung I, Trump DL. Epigenetic silencing of CYP24 in the tumor microenvironment. The Journal of Steroid Biochemistry and Molecular Biology. 121: 338-42. PMID 20304059 DOI: 10.1016/J.Jsbmb.2010.03.046 |
0.576 |
|
2010 |
Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C, Zetter BR. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 2503-8. PMID 20133800 DOI: 10.1073/Pnas.0910649107 |
0.334 |
|
2010 |
Chung I, Barrows C, Wilson A, Rummel N, Badaruddin S, Mizokami A, Banyard J, Zetter B. Abstract 1551: Benzimidazole as novel therapeutic agent for metastatic prostate cancer Cancer Research. 70: 1551-1551. DOI: 10.1158/1538-7445.Am10-1551 |
0.38 |
|
2009 |
Chung I, Han G, Seshadri M, Gillard BM, Yu WD, Foster BA, Trump DL, Johnson CS. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Research. 69: 967-75. PMID 19141646 DOI: 10.1158/0008-5472.Can-08-2307 |
0.543 |
|
2007 |
Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS, Trump DL. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. The Journal of Steroid Biochemistry and Molecular Biology. 103: 768-70. PMID 17368191 DOI: 10.1016/J.Jsbmb.2006.12.042 |
0.585 |
|
2007 |
Chung I, Karpf AR, Muindi JR, Conroy JM, Nowak NJ, Johnson CS, Trump DL. Epigenetic silencing of CYP24 in tumor-derived endothelial cells contributes to selective growth inhibition by calcitriol. The Journal of Biological Chemistry. 282: 8704-14. PMID 17244627 DOI: 10.1074/Jbc.M608894200 |
0.573 |
|
2006 |
Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology. 70: 447-57. PMID 17237620 DOI: 10.1159/000098872 |
0.58 |
|
2006 |
Chung I, Wong MK, Flynn G, Yu WD, Johnson CS, Trump DL. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells. Cancer Research. 66: 8565-73. PMID 16951169 DOI: 10.1158/0008-5472.Can-06-0905 |
0.59 |
|
2006 |
Conroy T, Marchal F, Blazeby JM, Matsubara T, Shintani K, Wakabayashi T, Matsumine A, Uchida A, Chung I, Romano M, Modzelewski RA, Johnson CS, Trump DL, Raderer M, Wöhrer S, et al. Contents Vol. 70, 2006 Oncology. 70: 503-506. DOI: 10.1159/000100118 |
0.406 |
|
2006 |
Conroy T, Marchal F, Blazeby JM, Matsubara T, Shintani K, Wakabayashi T, Matsumine A, Uchida A, Chung I, Romano M, Modzelewski RA, Johnson CS, Trump DL, Raderer M, Wöhrer S, et al. Subject Index Vol. 70, 2006 Oncology. 70: 500-502. DOI: 10.1159/000100117 |
0.395 |
|
Show low-probability matches. |